These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31549319)

  • 1. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
    Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
    Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
    World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
    Takahashi K; Watanabe M; Kozuki R; Toihata T; Okamura A; Imamura Y; Mine S; Ishizuka N
    Ann Surg Oncol; 2019 Oct; 26(11):3727-3735. PubMed ID: 31313039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
    Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
    Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
    Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
    Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
    Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
    World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis.
    Yamamoto M; Ozawa S; Koyanagi K; Kazuno A; Ninomiya Y; Yatabe K; Higuchi T; Kanamori K; Tajima K
    Surg Today; 2023 Jun; 53(6):692-701. PubMed ID: 36763134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of early postoperative factors on changes in skeletal muscle mass after esophagectomy in older patients with esophageal cancer.
    Harada T; Tatematsu N; Ueno J; Koishihara Y; Konishi N; Fukushima T; Fujiwara H; Fujita T; Hijikata N; Wada A; Ishikawa A; Tsuji T
    Eur Geriatr Med; 2023 Feb; 14(1):203-210. PubMed ID: 36586085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma.
    Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 30809629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study.
    Kim KW; Lee K; Lee JB; Park T; Khang S; Jeong H; Ko CS; Yook JH; Kim BS; Lee IS
    BMC Cancer; 2021 Feb; 21(1):157. PubMed ID: 33579228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Early Postoperative Change in Total Psoas Muscle Area and Long-term Prognosis in Esophagectomy for Patients with Esophageal Cancer.
    Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
    Ann Surg Oncol; 2021 Oct; 28(11):6378-6387. PubMed ID: 33786679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia, the depletion of muscle mass, an independent predictor of respiratory complications after oncological esophagectomy.
    Soma D; Kawamura YI; Yamashita S; Wake H; Nohara K; Yamada K; Kokudo N
    Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30239649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
    Fidler MJ; Borgia JA; Bonomi PD; Shah P
    Ann Surg Oncol; 2019 Nov; 26(12):3807-3808. PubMed ID: 31471841
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
    Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
    Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer?
    Kemper M; Molwitz I; Krause L; Reeh M; Burdelski C; Kluge S; Yamamura J; Izbicki JR; de Heer G
    Clin Nutr; 2021 Jun; 40(6):3729-3740. PubMed ID: 34130018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.
    Fujishima S; Tsujimoto H; Nagata K; Sugasawa H; Nomura S; Ito N; Harada M; Sugihara T; Ishibashi Y; Kouzu K; Shinmoto H; Kishi Y; Ueno H
    Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):84-90. PubMed ID: 32914386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.
    Elliott JA; Doyle SL; Murphy CF; King S; Guinan EM; Beddy P; Ravi N; Reynolds JV
    Ann Surg; 2017 Nov; 266(5):822-830. PubMed ID: 28796017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Optimal Definition of Sarcopenia for Predicting Postoperative Pneumonia after Esophagectomy in Patients with Esophageal Cancer.
    Nambara M; Miki Y; Tamura T; Yoshii M; Toyokawa T; Tanaka H; Lee S; Muguruma K; Shibata T; Ohira M
    World J Surg; 2021 Oct; 45(10):3108-3118. PubMed ID: 34189621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Significance of Skeletal Muscle Loss After Esophagectomy for Esophageal Cancer.
    Nakashima Y; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):499. PubMed ID: 31754911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.